MACULOGIX

maculogix-logo

MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.

#SimilarOrganizations #People #Financial #Website #More

MACULOGIX

Social Links:

Industry:
Health Care Health Diagnostics Therapeutics

Founded:
2004-01-01

Address:
Harrisburg, Pennsylvania, United States

Country:
United States

Website Url:
http://www.maculogix.com

Total Employee:
51+

Status:
Active

Contact:
717-583-1220

Email Addresses:
[email protected]

Total Funding:
64.33 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Sitelinks Search Box


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

opus-genetics-logo

Opus Genetics

Opus Genetics is a gene therapy company for ultra-rare blinding conditions.


Current Advisors List

not_available_image

Larry Norton Board of Directors @ MacuLogix
Board_member

not_available_image

John G. Edwards CEO & Board of Directors @ MacuLogix
Board_member

bill-mcphee_image

Bill McPhee Board of Directors @ MacuLogix
Board_member

not_available_image

Ron Thiboutot Board of Directors @ MacuLogix
Board_member

william-h-grace_image

William H. Grace VP, Engineering @ MacuLogix
Board_member

nathan-dau_image

Nathan Dau Board Member @ MacuLogix
Board_member
2019-03-01

Current Employees Featured

gregory-r-jackson_image

Gregory R. Jackson
Gregory R. Jackson Chief Technology Officer @ MacuLogix
Chief Technology Officer
2017-01-01

bill-mcphee_image

Bill McPhee
Bill McPhee CEO @ MacuLogix
CEO
2016-12-01

Founder


gregory-r-jackson_image

Gregory R. Jackson

Investors List

berwind-private-equity_image

Berwind Private Equity

Berwind Private Equity investment in Series D - MacuLogix

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series D - MacuLogix

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series D - MacuLogix

life-sciences-greenhouse-of-pennsylvania_image

Life Sciences Greenhouse of Pennsylvania

Life Sciences Greenhouse of Pennsylvania investment in Series D - MacuLogix

fisk-ventures_image

Fisk Ventures

Fisk Ventures investment in Series D - MacuLogix

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Debt Financing - MacuLogix

horizon-technology-finance_image

Horizon Technology Finance

Horizon Technology Finance investment in Debt Financing - MacuLogix

life-sciences-greenhouse-of-pennsylvania_image

Life Sciences Greenhouse of Pennsylvania

Life Sciences Greenhouse of Pennsylvania investment in Venture Round - MacuLogix

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series C - MacuLogix

berwind-private-equity_image

Berwind Private Equity

Berwind Private Equity investment in Series C - MacuLogix

Official Site Inspections

http://www.maculogix.com Semrush global rank: 2.51 M Semrush visits lastest month: 7.02 K

  • Host name: 104.21.80.1
  • IP address: 104.21.80.1
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "MacuLogix"

Making Dark Adaptation Testing the Standard of AMD Care …

Feb 3, 2022 · We equip eye care professionals with the resources needed to help identify AMD early & monitor disease progression. We are The AMD Experts!See details»

LumiThera, Inc. Announces Purchase of MacuLogix Assets …

SEATTLE, July 26, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today …See details»

MacuLogix - Crunchbase Company Profile & Funding

MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through …See details»

MacuLogix Videos I This is the Story of …

Co-founder and Chief Technology Officer, Gregory R. Jackson, PhD, reveals how rethinking AMD helped bring about the birth of the AdaptDx ® automated dark adaptometer (eventually leading to the evolution of the head-mounted …See details»

Empowering Eye Care Professionals · We Are …

MacuLogix ® is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage AMD patients early, before irreversible vision loss has occurred. We can help you …See details»

MacuLogix, Inc. Company Profile | Harrisburg, PA

Find company research, competitor information, contact details & financial data for MacuLogix, Inc. of Harrisburg, PA. Get the latest business insights from Dun & Bradstreet.See details»

MacuLogix Company Profile 2024: Valuation, …

Developer of optical testing equipment designed to increase early detection of age-related macular degeneration.See details»

MacuLogix's Leadership Team - Team members and org …

MacuLogix has a leadership team with a history of experience in sales, marketing, communications, business administration, accounting, and psychology. The team also has …See details»

LumiThera, Inc. Announces Purchase of MacuLogix Assets …

SEATTLE, July 26, 2022 /CNW/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today …See details»

MacuLogix's Board of Directors Team - Team members …

The board of directors at MacuLogix has experience in finance, management, and organizations from their time at Northwestern University's Kellogg School of Management. They have also …See details»

MacuLogix - Contacts, Employees, Board Members, …

MacuLogix has 1 current employee profile, Chief Technology Officer Gregory R. Jackson. MacuLogix has 6 board members and advisors, including Larry Norton.See details»

MacuLogix AdaptDx Pro – Artefact

Transform MacuLogix’s groundbreaking automated dark adaptometer from a tabletop research device into a patient-centered, wearable system to enable eye care professionals to more …See details»

Explore the AdaptDx Pro Library of Resources - MacuLogix

Eye care professionals demonstrate how the AdaptDx Pro ® benefits their practices, while patients explain how an AMD diagnosis with the device changed their lives. MacuLogix ® …See details»

AdaptDx Pro by MacuLogix Has Received a Medical …

Sep 28, 2020 · MacuLogix, Inc. equips eye care professionals with the instrument, tools and education needed to effectively diagnose, manage and treat patients with age-related macular …See details»

Welcome to the AMD Academy!

Explore this site to find training demonstrations, clinical and marketing resources, and much more tailored for AdaptDx technology users.See details»

This is the Story of Maculogix - YouTube

Co-founder and Chief Technology Officer, Gregory R. Jackson, PhD, reveals how rethinking AMD helped bring about the birth of the AdaptDx automated dark adapt...See details»

AdaptDx Pro: Measure the Speed of Dark Adaptation

Backed by 20 years of proven clinical research, the AdaptDx Pro ® is a revolutionary new way to test patients. Advanced, precision eye tracking technology automatically aligns with the eye to …See details»

MacuLogix Moves to Wind Down Operations as a 'Going …

Formed in 2008 and base here in Middletown, MacuLogix specializes in the detection of age-related macular degeneration (AMD), the largest cause of blindness in the western world.See details»

MacuLogix Research & Publications Using Dark …

Automated dark adaptometers created by MacuLogix are used worldwide for research to help understand AMD and improve treatment options. Explore over 40 peer-reviewed publications …See details»

MacuLogix raises $5M to back FDA-cleared early AMD …

Aug 4, 2015 · Hummelstown, PA-based startup MacuLogix has raised $5 million to back its FDA-cleared diagnostic test for dark adaptation function disorders, which include age-related …See details»

linkstock.net © 2022. All rights reserved